Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.43 |
| ▸ | TUBB | P07437 | 3/20 | 0.43 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.43 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.43 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.43 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.43 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.43 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.43 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.43 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.43 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.43 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.43 |
| ▸ | TUBB6 | Q9BUF5 | 3/20 | 0.43 |
| ▸ | TUBB2B | Q9BVA1 | 3/20 | 0.43 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23622414 | 0.87 | PTGS2 (0.47) | PTGS2HTR2AHTR2CHTR2BTUBB4A | |
| SCHEMBL14594729 | 0.84 | HTR2A (0.55) | PTGS2HTR2AHTR2CHTR2BTUBB4A | |
| SCHEMBL23070508 | 0.80 | CA2 (0.55) | ALDH1A1LMNAAOC3CYP19A1ACHE | |
| SCHEMBL31432873 | 0.80 | RAB9A (0.35) | PTGS2ALDH1A1LMNACYP3A4MAPT | |
| SCHEMBL15227173 | 0.77 | GRIN2D (0.46) | ALDH1A1CYP19A1CYP3A4MAPT | |
| SCHEMBL17913311 | 0.76 | ALDH1A1 (0.39) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL21796409 | 0.76 | SMN1; SMN2 (0.40) | HTR2AHTR2CHTR2BALDH1A1LMNA | |
| SCHEMBL13623245 | 0.75 | KAT2B (0.34) | ALDH1A1KDM4E | |
| SCHEMBL6849735 | 0.75 | PTGS2 (0.57) | PTGS2HTR2AHTR2CHTR2BTUBB4A | |
| SCHEMBL18703775 | 0.74 | S1PR1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-04-24 | — | — | US | disclosed |
| EP-3481819-B1 | COMPOUNDS AND THEIR USE FOR REDUCING URIC ACID LEVELS | ACQUIST LLC (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-109476642-B | Compounds and their use for reducing uric acid levels | 阿奎斯特有限责任公司 | 2022-01-25 | — | — | CN | disclosed |
| US-20210236495-A1 | Compounds and Their Use for Reducing Uric Acid Levels | ACQUIST LLC (US) | 2021-08-05 | — | — | US | disclosed |
| WO-2021137665-A1 | 1, 2, 3-TRIAZOLE DERIVATIVE COMPOUND AS HSP90 INHIBITOR, AND USE THEREOF | 이화여자대학교 산학협력단 | 2021-07-08 | — | — | WO | disclosed |
| WO-2021137665-A1 | 1, 2, 3-TRIAZOLE DERIVATIVE COMPOUND AS HSP90 INHIBITOR, AND USE THEREOF | 이화여자대학교 산학협력단 | 2021-07-08 | — | — | WO | disclosed |
| US-11020397-B2 | Compounds and their use for reducing uric acid levels | ACQUIST LLC (US) | 2021-06-01 | — | — | US | disclosed |
| US-20200268757-A1 | Compounds and Their Use for Reducing Uric Acid Levels | ACQUIST LLC (US) | 2020-08-27 | — | — | US | disclosed |
| US-20200197393-A9 | Compounds and Their Use for Reducing Uric Acid Levels | ACQUIST LLC | 2020-06-25 | — | — | US | disclosed |
| US-10688095-B2 | Compounds and their use for reducing uric acid levels | ACQUIST LLC (US) | 2020-06-23 | — | — | US | disclosed |
| EP-3481819-A1 | COMPOUNDS AND THEIR USE FOR REDUCING URIC ACID LEVELS | Acquist LLC (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20190117654-A1 | Compounds and Their Use for Reducing Uric Acid Levels | ACQUIST LLC (US) | 2019-04-25 | — | — | US | disclosed |
| WO-2018009615-A9 | COMPOUNDS AND THEIR USE FOR REDUCING URIC ACID LEVELS | ACQUIST LLC (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018009615-A1 | COMPOUNDS AND THEIR USE FOR REDUCING URIC ACID LEVELS | ACQUIST LLC (US) | 2018-01-11 | — | — | WO | disclosed |
| US-20170231260-A1 | HYDROPHOBIN MIMICS: PROCESS FOR PREPARATION THEREOF | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2017-08-17 | — | — | US | disclosed |
| CN-103044341-B | 1, 2, 3-triazole-dithiocarbamate-urea complex, as well as preparation method and application thereof | UNIV ZHENGZHOU | 2015-07-01 | — | — | CN | disclosed |
| CN-102850283-B | Triazolyl-containing amino-dithio formic ether compound as well as preparation method and application of compound | ZHENGZHOU UNIVERSITY (CN) | 2014-10-22 | — | — | CN | disclosed |
| CN-103054869-A | Application of amino dithio formic ester compound with triazolyl in preparing medicine taking LSD1 (Lysine Specificity Demethylase 1) as target | UNIV ZHENGZHOU | 2013-04-24 | — | — | CN | disclosed |
| CN-103044341-A | 1, 2, 3-triazole-dithiocarbamate-urea complex, as well as preparation method and application thereof | UNIV ZHENGZHOU | 2013-04-17 | — | — | CN | disclosed |
| CN-102850283-A | Triazolyl-containing amino-dithio formic ether compound as well as preparation method and application of compound | UNIV ZHENGZHOU | 2013-01-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170231260-A1 | HYDROPHOBIN MIMICS: PROCESS FOR PREPARATION THEREOF | CHN2, NEFM, HGF | PTGS2 4329/4885HTR2A 4187/4885HTR2C 4250/4885 |
| US-10688095-B2 | Compounds and their use for reducing uric acid levels | XDH, OAT, UGT2B7 | PTGS2 3056/4885HTR2A 1698/4885HTR2C 2056/4885 |
| US-20210236495-A1 | Compounds and Their Use for Reducing Uric Acid Levels | XDH, OAT, URB2 | PTGS2 2744/4885HTR2A 2822/4885HTR2C 3165/4885 |
| US-20200268757-A1 | Compounds and Their Use for Reducing Uric Acid Levels | XDH, OAT, URB2 | PTGS2 2744/4885HTR2A 2822/4885HTR2C 3165/4885 |
| US-20250129016-A1 | PHOTOREDOX METHODS FOR RADIOCYANATION OF ARENES AND USE THEREOF | RCC2, PPOX, FTO | PTGS2 3179/4885HTR2A 3440/4885HTR2C 2168/4885 |
| US-11020397-B2 | Compounds and their use for reducing uric acid levels | XDH, OAT, UGT2B7 | PTGS2 3056/4885HTR2A 1698/4885HTR2C 2056/4885 |
| US-20200197393-A9 | Compounds and Their Use for Reducing Uric Acid Levels | XDH, OAT, URB2 | PTGS2 2744/4885HTR2A 2822/4885HTR2C 3165/4885 |
| US-20190117654-A1 | Compounds and Their Use for Reducing Uric Acid Levels | XDH, OAT, URB2 | PTGS2 2744/4885HTR2A 2822/4885HTR2C 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.